Heteroplasmic mitochondrial DNA mutations in frontotemporal lobar degeneration.
View / Open Files
Publication Date
2022-06Journal Title
Acta Neuropathol
ISSN
0001-6322
Publisher
Springer Science and Business Media LLC
Volume
143
Issue
6
Pages
687-695
Language
eng
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Nie, Y., Murley, A., Golder, Z., Rowe, J. B., Allinson, K., & Chinnery, P. F. (2022). Heteroplasmic mitochondrial DNA mutations in frontotemporal lobar degeneration.. Acta Neuropathol, 143 (6), 687-695. https://doi.org/10.1007/s00401-022-02423-6
Abstract
Frontotemporal lobar degeneration (FTLD) is a common cause of young onset dementia and is characterised by focal neuropathology. The reasons for the regional neuronal vulnerability are not known. Mitochondrial mechanisms have been implicated in the pathogenesis of FTLD, raising the possibility that frontotemporal regional mutations of mitochondrial DNA (mtDNA) are contributory causes. Here we applied dual sequencing of the entire mtDNA at high depth to identify high-fidelity single nucleotide variants (mtSNVs) and mtDNA rearrangements in post mortem brain tissue of people affected by FTLD and age-matched controls. Both mtSNVs and mtDNA rearrangements were elevated in the temporal lobe, with the greatest burden seen in FTLD. mtSNVs found in multiple brain regions also reached a higher heteroplasmy levels in the temporal lobe. The temporal lobe of people with FTLD had a higher burden of ribosomal gene variants predicted to affect intra-mitochondrial protein synthesis, and a higher proportion of missense variants in genes coding for respiratory chain subunits. In conclusion, heteroplasmic mtDNA variants predicted to affect oxidative phosphorylation are enriched in FTLD temporal lobe, and thus may contribute to the regional vulnerability in pathogenesis.
Keywords
DNA, Mitochondrial, Frontotemporal Dementia, Frontotemporal Lobar Degeneration, Heteroplasmy, Humans, Mutation
Sponsorship
Addenbrooke's Charitable Trust (ACT) (25/16A)
Cambridge University Hospitals NHS Foundation Trust (CUH) (146281)
Evelyn Trust (17/08)
WBH Foundation (via Cambridge in America) (Unknown)
Wellcome Trust (212219/Z/18/Z)
Wellcome Trust (103838/Z/14/Z)
MRC (MR/S035699/1)
National Institute for Health Research (IS-BRC-1215-20014)
Medical Research Council (MC_UU_00005/12)
Cambridge University Hospitals NHS Foundation Trust (CUH) (146281)
Identifiers
35488929, PMC9107417
External DOI: https://doi.org/10.1007/s00401-022-02423-6
This record's URL: https://www.repository.cam.ac.uk/handle/1810/337801
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk